COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.

Amit, Sharon; Regev-Yochay, Gili; Afek, Arnon; Kreiss, Yitshak; Leshem, Eyal

Amit, Sharon; Regev-Yochay, Gili; Afek, Arnon; Kreiss, Yitshak; Leshem, Eyal.

Amit S; Chaim Sheba Medical Centre, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Regev-Yochay G; Chaim Sheba Medical Centre, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Afek A; Chaim Sheba Medical Centre, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Kreiss Y; Chaim Sheba Medical Centre, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Leshem E; Chaim Sheba Medical Centre, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel. Electronic address: eyal.leshem@sheba.health.gov.il.

Lancet ; 397(10291): 2249-2250, 2021 06 12.

Article in English | MEDLINE | ID: covidwho-1275779

Subject(s)

COVID-19 Vaccines; COVID-19; Diagnostic Tests, Routine; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)01059-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google